Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy

NCT06437431 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT06437431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06437431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Phase 2/3
Overall status
Withdrawn
Start date
September 30, 2026
Completion date
October 31, 2030
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke